Savara, Inc. (SVRA)
4.83
-0.05
(-1.02%)
USD |
NASDAQ |
Oct 08, 16:00
4.71
-0.12
(-2.48%)
Pre-Market: 08:40
Savara Total Return Level : 4.83 for Oct. 8, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 08, 2026 | 4.83 |
| October 07, 2026 | 4.88 |
| October 06, 2026 | 4.65 |
| October 05, 2026 | 4.78 |
| October 02, 2026 | 4.81 |
| October 01, 2026 | 5.045 |
| September 30, 2026 | 5.16 |
| September 29, 2026 | 5.08 |
| September 28, 2026 | 5.07 |
| September 25, 2026 | 5.00 |
| September 24, 2026 | 5.07 |
| September 23, 2026 | 5.00 |
| September 22, 2026 | 5.30 |
| September 21, 2026 | 5.45 |
| September 18, 2026 | 5.37 |
| September 17, 2026 | 5.42 |
| September 16, 2026 | 5.13 |
| September 15, 2026 | 5.26 |
| September 14, 2026 | 5.34 |
| September 11, 2026 | 5.30 |
| September 10, 2026 | 5.32 |
| September 09, 2026 | 5.415 |
| September 08, 2026 | 5.53 |
| September 04, 2026 | 5.37 |
| September 03, 2026 | 5.37 |
| Date | Value |
|---|---|
| September 02, 2026 | 5.46 |
| September 01, 2026 | 5.35 |
| August 31, 2026 | 5.39 |
| August 28, 2026 | 5.26 |
| August 27, 2026 | 5.49 |
| August 26, 2026 | 5.61 |
| August 25, 2026 | 5.60 |
| August 24, 2026 | 5.56 |
| August 21, 2026 | 5.59 |
| August 20, 2026 | 5.49 |
| August 19, 2026 | 5.58 |
| August 18, 2026 | 5.37 |
| August 17, 2026 | 5.37 |
| August 14, 2026 | 5.38 |
| August 13, 2026 | 5.27 |
| August 12, 2026 | 5.70 |
| August 11, 2026 | 5.57 |
| August 10, 2026 | 5.73 |
| August 07, 2026 | 5.83 |
| August 06, 2026 | 5.79 |
| August 05, 2026 | 5.51 |
| August 04, 2026 | 5.41 |
| August 03, 2026 | 5.33 |
| July 31, 2026 | 5.46 |
| July 30, 2026 | 5.54 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Gilead Sciences, Inc. | 215.59 |
| Insmed, Inc. | 100.48 |
| United Therapeutics Corp. | 532.78 |
| Vertex Pharmaceuticals, Inc. | 503.25 |
| ACADIA Pharmaceuticals, Inc. | 19.58 |